Pisaturo, M. et al. 2019. Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis. Acta Biomedica Atenei Parmensis. 90, 2 (May 2019), 187–196. DOI:https://doi.org/10.23750/abm.v90i2.8374.